VICKI SURGENAVIC: Open Payments
NPI 1679154736 · SEWICKLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 11 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $238 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $346 |
| Janssen Pharmaceuticals, Inc | 4 | $339 |
| Teva Pharmaceuticals USA, Inc. | 1 | $115 |
| Vanda Pharmaceuticals Inc. | 1 | $114 |
| ABBVIE INC. | 1 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $91 |
Products named: INVEGA SUSTENNA, LYBALVI, ARISTADA, UZEDY, FANAPT, VRAYLAR, CAPLYTA.
Industry payments across PA — which companies pay providers there.
